Pharsight

Drugs that contain Terbinafine

1. Lamisil patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6005001

(Pediatric)

KARO HLTHCARE Pharmaceutical composition
Nov, 2012

(11 years ago)

US5856355

(Pediatric)

KARO HLTHCARE Pharmaceutical composition
Nov, 2012

(11 years ago)

US5681849 KARO HLTHCARE Pharmaceutical composition for topical applications
Oct, 2014

(9 years ago)

US5681849

(Pediatric)

KARO HLTHCARE Pharmaceutical composition for topical applications
Apr, 2015

(9 years ago)

Market Authorisation Date: 29 April, 1998

Treatment: NA

Dosage: GEL;TOPICAL

More Information on Dosage

LAMISIL family patents

Family Patents

2. Lamisil At patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5856355

(Pediatric)

KARO HLTHCARE Pharmaceutical composition
Nov, 2012

(11 years ago)

US5681849 KARO HLTHCARE Pharmaceutical composition for topical applications
Oct, 2014

(9 years ago)

US5681849

(Pediatric)

KARO HLTHCARE Pharmaceutical composition for topical applications
Apr, 2015

(9 years ago)

Market Authorisation Date: 24 July, 2006

Treatment: NA

Dosage: GEL;TOPICAL

More Information on Dosage

LAMISIL AT family patents

Family Patents